Screening at the Frontlines: The Global Rise of AI-Powered Mobile and Biomarker Diagnostics for Leprosy

Posted on 14 January 2025 by BGT

How Smart Questionnaires and the WHO Skin App are Taking AI into Endemic Communities

In the global fight against leprosy, early case detection is the only definitive way to interrupt transmission. Historically, this required in-person clinical exams conducted by rare medical specialists. Publications from June 2024 reveal a technological shift: field-ready AI applications are moving diagnosis away from centralized hospitals and directly into the hands of community health workers.

The WHO Skin NTD App and Field Algorithms

A prime example of this frontline revolution is the WHO Skin NTD mobile application reviewed in mid-2024. This software brings logical offline and AI algorithms directly to smartphones to tackle skin-related Neglected Tropical Diseases (NTDs), with a major emphasis on leprosy.

The app operates seamlessly in areas with minimal internet connectivity, allowing rural healthcare workers to take photos of suspicious skin lesions. The integrated AI algorithm then compares the image metadata against massive datasets of dermatological manifestations. In 2024 field testing across endemic nations like Kenya, these smartphone-based AI algorithms achieved a diagnostic sensitivity of roughly 80% compared to certified dermatologists. By supporting multiple languages—such as English, French, and Kinyarwanda—the app allows minimally trained local workers to accurately triage leprosy cases right at the patient’s doorstep.

MaLeSQs: The Machine Learning Tool for Neurological Screening

Simultaneously, major breakthroughs advanced the validation of the Leprosy Suspicion Questionnaire (LSQ). The LSQ is a digital screening framework consisting of 14 specific questions focused entirely on early neurological indicators, such as a loss of thermal sensitivity or difficulty buttoning a shirt.

In 2024, researchers perfected MaLeSQs (Machine Learning Leprosy Suspicion Questionnaire), an AI framework that evaluates a patient’s combined answers. Utilizing four distinct mathematical learning paradigms (including Support Vector Machines and Random Forest), MaLeSQs utilizes “Shapley values” to weigh the clinical significance of a patient’s responses.

When deployed alongside new multi-antibody blood biomarkers, this AI questionnaire tool achieved a staggering 100% sensitivity during validation studies. It accurately flagged all early-stage, asymptomatic individuals who harboured the Mycobacterium leprae bacillus before they developed visible physical deformities. This affordable, scalable combination paves a clear path toward national, large-scale screening programs designed to systematically wipe out leprosy transmission cycles globally.

Posted in Latest News | Tagged , , , | Comments Off on Screening at the Frontlines: The Global Rise of AI-Powered Mobile and Biomarker Diagnostics for Leprosy

Revolutionising the Clinic: How AI is Transforming Leprosy Management and Overcoming Diagnostic Hurdles

Posted on 14 April 2024 by BGT

Published Research Highlights 2024 Paradigm Shifts in Clinical Care

Leprosy (Hansen’s disease) remains a persistent global public health challenge, with the World Health Organization (WHO) tracking more than 170,000 new cases annually. A major roadblock to total eradication is diagnostic delay; initial symptoms are often subtle, leading to transmission and permanent nerve damage. However, landmark peer-reviewed research published in March 2024 indicates that Artificial Intelligence (AI) is providing clinicians with a powerful toolkit to entirely reshape how the disease is managed.

Predicting and Preventing Misdiagnosis

A core focus of the 2024 clinical perspectives published in Frontiers in Medicine is the deployment of machine learning algorithms to address the high rate of clinical misdiagnosis. Because leprosy is an immunologically complex spectral disorder, its early skin lesions and joint pain frequently mimic autoimmune conditions like sarcoidosis or rheumatoid arthritis.

By processing multifaceted retrospective patient data—including clinical, social, and epidemiological characteristics—machine learning models are now trained to identify individuals at a high risk of being misdiagnosed. These data-driven support tools act as a digital safety net for frontline healthcare providers, alerting them to re-evaluate cases before irreversible physical complications occur.

Enhancing Therapeutic Compliance and Monitoring

Beyond initial detection, AI systems are expanding into the clinical management of ongoing treatments. Standard leprosy care relies heavily on Multi-Drug Therapy (MDT), a strict regimen spanning several months. Non-compliance can trigger antimicrobial resistance and severe immunological leprosy reactions.

The 2024 research highlights how logical AI algorithms can:

  • Ensure MDT Compliance: Automated systems track patient adherence and predict who might drop out of care.
  • Map Geographical Coverage: Predictive modelling evaluates the distribution of medication to ensure high-risk, endemic communities receive adequate supply.
  • Detect Adverse Reactions: Smart systems monitor patient logs to flag early indicators of adverse drug reactions or nerve impairment.

By digitising and automating these oversight tasks, AI acts as a vital force-multiplier in areas facing a severe shortage of trained dermatologists and public health workers.

Posted in Latest News | Tagged | Comments Off on Revolutionising the Clinic: How AI is Transforming Leprosy Management and Overcoming Diagnostic Hurdles

What is AI for Health

Posted on 12 June 2023 by BGT

About Microsoft AI for Health

AI for Health is a $60 million, five-year philanthropic program from Microsoft, created to empower nonprofits, researchers, and organizations tackling some of the toughest challenges in global health. 

About Microsoft AI for Health

  • Diagnostics and Screening: AI algorithms can analyze medical imaging (like mammograms, MRIs, and X-rays) to detect abnormalities, such as early-stage cancers or neurological changes, with high precision.
  • Drug Discovery: By processing vast amounts of biological and chemical data, AI significantly reduces the time and cost required to discover and develop new pharmaceutical treatments.
  • Administrative Automation: AI tools, like ambient voice recognition, transcribe doctor-patient conversations in real-time, drastically reducing time spent on administrative tasks and medical note-taking.
  • Personalized & Predictive Medicine: AI can combine a patient’s genetic data, medical history, and real-time vital signs from wearable devices to predict illnesses (like Alzheimer’s) and recommend highly targeted therapies.
  • Virtual Assistants and Triage: Chatbots and AI-driven symptom checkers help triage patients and direct them to the appropriate level of care, such as the NHS 111 Online service in the UK.

AI is transforming healthcare by easing the strain on medical professionals, reducing wait times, and pushing towards precision medicine. However, its implementation requires careful management of data privacy, ethical governance, and regulatory oversight to ensure patient safety.

See also: https://www.microsoft.com/en-us/ai/ai-for-health 

Posted in Information | Tagged , , | Comments Off on What is AI for Health

AI Analysis of Images for Early Leprosy Detection.

Posted on 11 July 2022 by BGT

The AI4Leprosy initiative, a partnership involving the Novartis Foundation, Fiocruz, and Microsoft AI for Health, is utilising machine learning to analyse skin lesion photos for early leprosy detection. A study published in The Lancet Regional Health – Americas reported that this open-source tool achieves over 90% accuracy in identifying potential cases. Read the validation study at The Lancet.

Posted in Latest News | Tagged , , | Comments Off on AI Analysis of Images for Early Leprosy Detection.

Pixels Against a Persistent Plaque

Posted on 13 June 2022 by BGT

How AI is Front-lining the Battle to End Leprosy.

The global mission to eradicate leprosy has found an unexpected frontline weapon: the smartphone camera. Long restricted by a critical shortage of specialised medical personnel in remote, high-risk regions, healthcare systems are turning to artificial intelligence to uncover early signs of the ancient illness before it inflicts irreversible harm.

At the vanguard of this digital health pivot is AI4Leprosy, a collaborative initiative uniting the Novartis Foundation, Microsoft AI for Health, and Brazil’s Instituto Oswaldo Cruz (Fiocruz). The partnership has successfully trained machine learning algorithms using thousands of anonymised skin lesion photographs and clinical data points collected across endemic regions. In a definitive validation study published in The Lancet Regional Health – Americas, researchers demonstrated that this open-source tool achieves over 90% accuracy in detecting leprosy when evaluating skin images alongside local symptoms.

By transforming standard consumer smartphones into functional diagnostic instruments, this technology directly targets the primary vulnerability of traditional disease control: delayed recognition. Public health experts emphasise that early detection is the ultimate linchpin in leprosy management. Catching the underlying bacterial infection (Mycobacterium leprae) early prevents the onset of permanent nerve damage and the severe physical disabilities historically tied to the condition’s social stigma.

Posted in Latest News | Tagged , | Comments Off on Pixels Against a Persistent Plaque

What is AI4Leprosy?

Posted on 1 May 2022 by BGT

The AI4Leprosy diagnostic tool was officially launched in February 2022. It was developed through a collaborative partnership between the Novartis Foundation, Microsoft’s AI for Health team, and the Oswaldo Cruz Foundation (Fiocruz).

To achieve this, the project collected skin lesion images and patient data between 2018 and 2020 at a clinic in Rio de Janeiro, Brazil. The resulting AI model helps health workers and clinicians identify suspected leprosy lesions more quickly and accurately.

Posted in Information | Tagged , , | Comments Off on What is AI4Leprosy?

Global leprosy (‎Hansen’s Disease)‎ strategy 2021–2030

Posted on 1 May 2021 by BGT

The World Health Organization has published the benchmark Global Leprosy (Hansen’s Disease) Strategy 2021–2030: Towards Zero Leprosy, in which he global health community has committed to aggressive milestones.

The strategy mandates a 70% reduction in the annual number of new cases and requires 120 countries to report zero indigenous transmission by the end of the decade. The framework explicitly prioritises the integration of digital health and innovative active case detection to bridge diagnostic gaps in hard-to-reach populations.

Posted in Information | Tagged , | Comments Off on Global leprosy (‎Hansen’s Disease)‎ strategy 2021–2030

Leprosy microbes lead scientists to immune discovery

Posted on 31 July 2011 by BGT

Thanks to the opportunity that human leprosy infections provide for study of human immune responses, scientists have discovered how the body’s early warning system prompts a rapid immune response by two separate armies of defensive cells.

The researchers isolated immune cells in blood samples from healthy people and exposed the cells to a component of mycobacteria. They noted that the large white blood cells known as monocytes rapidly differentiated into the two distinct cell types, macrophages, which seek out and engulf the infectious bugs, and dendritic, or “antigen-presenting” cells, which seize distinctive pieces of the enemy and use them to “educate” and stir up a second immune response, known as “adaptive” immunity.

Until now, laboratory dish experiments had not revealed that the instantaneous or “innate” immune reaction, discovered less than 10 years ago, is mounted by two differently-specialized cells.

To read more about this discovery see Leprosy microbes lead scientists to immune discovery

Posted in Latest News | Tagged , | Comments Off on Leprosy microbes lead scientists to immune discovery

Delhi Has A Change of Heart for Sister Jean

Posted on 25 July 2011 by BGT

A few days ago newspapers and websites were reporting that London-born Jacqueline Jean McEwan, a Catholic nun from Britain who has spent 29 years caring for leprosy patients in Bengaluru, India, is being forced to give up her work and leave the country after Delhi refused to renew her residency permit. Sometimes known as the Mother Teresa of Sumanahalli, Sister Jean runs a mobile clinic for leprosy patients in Bengaluru.

We can now confirm that Sister Jean McEwan, has been given an extension to apply for residency visa. We think that this is the least that the authorities in Delhi could do for someone who has been helping the country’s sick for nearly 30 years.

For more on this story, see also these links from the Guardian:
Nun forced to leave India after 29 years of helping leprosy patients
India extends British nun’s stay after visa row

Posted in Latest News | Comments Off on Delhi Has A Change of Heart for Sister Jean

Awareness of Hansen’s Disease in the United States

Posted on 31 July 2010 by BGT

To some people, it might at first appear that leprosy or Hansen’s disease as it is properly known, is a disease of the third world, or of poverty torn countries, or confined to India. However, compiled statistics reveal that although it is comparatively rare in the United States, there are currently approximately 6,500 cases and about 3,300 require active medical management. One problem is that diagnosis in the US is often delayed because health care providers are unaware of Hansen’s disease (leprosy) and its symptoms.

Although Hansen’s disease is not a common infectious disease, it has not been eradicated from the US population, and is endemic, particularly in the Gulf Coast region. According to the Centers for Disease Control and Prevention (CDC) prevalence has remained relatively stable in the United States. Hansen’s disease is nationally notifiable, and in 2002, 96 cases occurring in the United States were reported to CDC. There are approximately 100 to 150 new cases diagnosed each year.

In 2008 (the most recent year for which data are available) 150 new cases were reported in the the United States, with the majority of these new cases (97 or 65%) reported in California, Florida, Hawaii, Louisiana, Massachusetts, New York and Texas.

Once you realize that even in the United States Hansen’s Disease is still a problem, all be it a small one, then you can appreciate the problem in less affluent countries. Awareness of Hansen’s Disease in the United States can contribute to the solution worldwide, and help to eradicate this disfiguring disease forever.

Posted in Latest News | Leave a comment